Tom qab xa tawm 150% cov nyiaj khwv tau los ntawm lub quarter dhau los, Wall Street kwv yees hu rau tus thawj coj tswj ntshav qab zib Khoom Ntsuas (PODD) txhawm rau tshaj tawm 261% EPS spike rau tag nrho lub xyoo. Qhov ntawd muaj PODD Tshuag teeb tsa tshiab muas point.
X
Raws li nyob rau hauv Massachusetts thiab nrhiav tau nyob rau hauv 2000, lub tuam txhab kho mob tshiab ua rau lub neej yooj yim dua rau cov neeg mob ntshav qab zib thiab lwm yam mob. Nws pab tib neeg tswj ntshav qab zib los ntawm nws txoj kev hloov pauv Omnipod Insulin Management System.
Los ntawm Omnipod cov khoom lag luam platform, Insulet muab lwm txoj hauv kev rau kev xa cov tshuaj insulin. Nrog rau kev tsim qauv yooj yim, hnav thiab tsis muaj dej, lub Pod pov tseg muab txog li peb hnub ntawm kev xa cov tshuaj insulin, tsis tas yuav pom lossis kov koob.
Insulet tseem txhawb nqa nws cov Pod los ntawm kev kho nws Omnipod thev naus laus zis platform rau kev xa cov tshuaj uas tsis yog-insulin, cov tshuaj hauv qab ntawm daim tawv nqaij hla lwm thaj chaw kho mob. Los ntawm kev rhuav tshem cov teeb meem ntawm kev kho cov tshuaj insulin twj tso kua mis, Insulet lub hom phiaj kom xa cov kev kho mob zoo tshaj plaws thiab cov txiaj ntsig kev noj qab haus huv mus ib txhis rau cov neeg mob ntshav qab zib.
Thaum lub Cuaj Hlis, lub tuam txhab tshaj tawm tias nws tau txais CE kos npe raws li European Kev Tswj Xyuas Khoom Siv Kho Mob rau nws Omnipod 5 Automated Insulin Delivery System rau cov neeg muaj hnub nyoog ob xyoos thiab laus dua uas muaj ntshav qab zib hom 1. (CE yog cov lus luv luv rau Fabkis "Conformite Europeenne," uas tau lees paub tias cov khoom lag luam ua tau raws li EU kev noj qab haus huv, kev nyab xeeb, thiab ib puag ncig.)
Insulet Hauv Kev Xav Tau Hauv Pawg Kev Lag Luam Muaj Zog
Hampered los ntawm cov nyiaj khwv tau los loj hlob thiab qhov nruab nrab "C" SMR Rating, Insulet tseem khwv tau 91 Puas Ntsuam Xyuas in Tshawb xyuas Tshuag.
Cov thawj coj hauv pawg kev lag luam khoom kho mob suav nrog Merit Medical Systems (MMSI), dexcom ua (DXCM) thiab Abiomed (ABMD), txhua qhov kev ntsuam xyuas 95 lossis zoo dua Composite Rating. Lub hli tas los, Johnson & Johnson (JNJ) tshaj tawm nws yuav tau Abiomed.
Kev lag luam nyob rau qib 25 ntawm 197 pawg IBD lem.
Txaus siab los ntawm cov kws tshuaj ntsuam kwv yees ntawm 261% cov nyiaj tau los loj hlob rau lub xyoo no, cov tub ua lag luam hauv tuam txhab tau pom tias xav tau PODD Tshuag. Insulet kis las "B" Kev Sib Nqus / Distribution Rating thiab 1.1 nce / down volume ratio. Ntxiv rau, 50 nyiaj nrog qhov "A +" kev ntsuam xyuas los ntawm IBD tus kheej cov khoom lag luam.
PODD Tshuag Koom Nrog Cov Neeg Ua Haujlwm Ua Haujlwm Tshiab Yuav Thaj Chaw
Tom qab tsoo qhov siab tshiab nyob rau lub Kaum Ib Hlis xyoo tas los, Insulet tau nkag mus rau lub sijhawm pob zeb uas nws tsim 40-lub lim tiam. ob chav hauv qab. Cov Tshuag tau mus ua ib lub khob qauv nrog 283.38 qhov yuav khoom.
Insulet gapped kom paub meej tias nkag tom qab tshaj tawm 150% cov nyiaj tau los loj hlob rau lub Kaum Ib Hlis 3. Nws tau nce ze li 23% hauv ib hnub ntawm tsab ntawv ceeb toom ntawd, tom qab ntawd rov qab los zom cov txiaj ntsig ntawd.
Thaum Insulet tau sau ntau qhov sib txawv ntawd, nws pom kev txhawb nqa ntawm nws 21-hnub kab thaum txuas ntxiv tsim nws tam sim no thiab tseem nyob rau theem pib tiaj tus. Hnub Friday ntxov, cov khoom lag luam tab tom sim kev txhawb nqa ntawm 21-hnub tus qauv. Qhov kev yuav khoom tshiab yog 320.10.
cov txheeb ze zog kab thim rov qab thaum lub hauv paus tiaj tus tsim tab sis tab tom sim mus kom ze rau qhov siab tshiab.
Lub caij no, Merit Medical tab tom sim qhov tshiab yuav tsam. Tus tsim khoom siv kho mob yog featured nyob rau hauv no lub Kaum Ib Hlis 18 kab.
Dexcom tseem tab tom teeb tsa, ntxiv kev lees paub lub zog hauv pab pawg,
Ua raws li Matthew Galgani ntawm Twitter ntawm @IBD_MGalgani.
KOJ YUAV TAU LI CAS:
Cov Nyiaj Khwv Kho Mob ua cov npe ntawm Kev Yuav Tshiab Los Ntawm Cov Nyiaj Tau Los Zoo Tshaj Plaws
Coj mus rhaub Bull Thiab Dais Markets nrog qhov yooj yim niaj hnub no
Tshawb nrhiav 3 Cov Lus Qhia Tseem Ceeb Los Saib Hauv Tshuag Mus Yuav Thiab Saib
Txheeb xyuas cov hauv paus thiab yuav cov ntsiab lus nrog Cov Qauv Pom Zoo no
Tau qhov twg los: https://www.investors.com/research/ibd-stock-analysis/insulet-diabetes-management-innovator-near-buy-point-on-estimates-for-261-percent-growth/?src=A00220&yptr = yahoo